Escosia, Juvylyn D.

HRN: 13-60-74  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2023
CEFUROXIME 500MG (TAB)
03/25/2023
04/01/2023
PO
500mg
BID X 7days
Urinary Tract Infection
Waiting Final Action 
03/25/2023
CEFTRIAXONE 1G (VIAL)
03/25/2023
03/31/2023
IV
1g
Q24
Tc Acute Pyelonephritis
Waiting Final Action 
03/27/2023
CEFUROXIME 1.5GM (VIAL)
03/27/2023
04/03/2023
IVTT
2g
OD
Uti
Waiting Final Action 
03/27/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/27/2023
04/03/2023
IV INFUSION
500mg
Q8
Uti
03/30/2023
METRONIDAZOLE 500MG (TAB)
03/30/2023
04/06/2023
PO
500mg Tab
BID
Empiric De-escalation
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: